Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats

An update on the role of leukotrienes in asthma

(2010) Teal S Hallstrand et al.   Current Opinion in Allergy and Clinical Immunology

A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?

(2010) Paul A Lapchak   EXPERT OPINION ON PHARMACOTHERAPY

Pranlukast Attenuates Ischemia-like Injury in Endothelial Cells Via Inhibiting Reactive Oxygen Species Production and Nuclear Factor-κB Activation

(2009) San-Hua Fang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Review of recent results of montelukast use as a monotherapy in children with mild asthma

(2008) U WAHN et al.   CLINICAL THERAPEUTICS

Cysteinyl leukotriene receptor CysLT1as a novel therapeutic target for allergic rhinitis treatment

(2008) Hideaki Shirasaki   EXPERT OPINION ON THERAPEUTIC TARGETS

Down-regulation of neurocan expression in reactive astrocytes promotes axonal regeneration and facilitates the neurorestorative effects of bone marrow stromal cells in the ischemic rat brain

(2008) Li Hong Shen et al.   GLIA